Breaking New Ground in Diagnostics of Infections

The InfectoGnostics Research Campus Jena is a public-private partnership breaking new ground in the diagnosis of infections. More than 30 partners from science, medicine and industry are jointly developing novel solutions for fast and cost-effective on-site diagnostics of infectious diseases.

Read more our mission and the concept of our campus.

The InfectoGnostics campus partner Nanozoo has developed a platform that is providing all analytic services and necessary compute clusters to make data analysis as easy as an online order.


More information:

Campus Partner Nanozoo: Analysis Services for Sequencing Data


Find out more about current advancements in diagnostics and infection research in our most recent news or browse through our news archive.

Using a microarray (left), InfectoGnostics researchers can simultaneously detect antibodies against SARS-CoV-2 (right) and against other infectious agents. (Illustration: InfectoGnostics/

Test Platform from Thuringia Checks Vaccination Status for Corona, Measles, Diphtheria & Tetanus simultaneously

Scientists at the InfectoGnostics Research Campus Jena have developed a new microarray that can detect antibodies against a wide range of infectious agents. With a single drop of the patient's blood, it is thus possible to test whether the immune system has responded to a vaccination or if there is antibody-mediated immunity after infection. The…

Read more
Wissenschaftler der fzmb GmbH betrachten mehrere "INTER-ARRAY"-Chips. Im Hintergrund ist ein solcher Microarray in Nahaufnahme bei der Auswertung zu sehen. (Foto: fzmb)

INTER-ARRAY test kit can differentiate more than 700 strains of Staphylococcus aureus

InfectoGnostics researchers have developed a test that can detect genetic characteristics of the bacterium Staphylococcus aureus and distinguish between more than 700 strains of this pathogen. Virulence factors and resistance genes, including those of the "multiresistant" variants (MRSA), can be quickly identified with the test kit. The…

Read more

InfectoGnostics and partners at the AMR Conference 2022 in Basel (Switzerland)

Together with its partners, the InfectoGnostics Research Campus participated in the AMR Conference in Basel from April 7 to 8, 2022 and presented scientific results and cooperation concepts from Jena. The AMR Conference is considered one of the most important international conferences that specifically address the topic of therapy and diagnostics…

Read more

Facilitating microbiome analyses: InfectoGnostics researchers remove irrelevant DNA already during sequencing

InfectoGnostics researchers at Jena University Hospital (JUH) and the Leibniz Institute for Photonic Technology (Leibniz-IPHT) have been able to show how irrelevant human DNA can be sorted out already during sequencing with nanopore systems to enable more precise analyses of microbiomes and bring them into routine diagnostics in the future. The…

Read more


Here you will find the current events in our network as well as an overview of previous events that have already taken place.

DiagnosTech-Pitch: Lung-on-chip models and their medical use (Dynamic 42)

30.09.2022, 14.00 Uhr15.00 Uhr

Hybrid (ZAF und online)

Diagnostics-4-Future Conference

12.10.2022, 10.00 Uhr01.07.2022, 18.00 Uhr

Konstanz (Bodensee)


15.11.2022, 08.00 Uhr16.11.2022, 18.00 Uhr



  • ADA

    Adaptable decentralised diagnostics for veterinary and human medicine

    In the "ADA" project, a cost-effective, open test platform for screening for Staphylococcus aureus / MRSA in human and veterinary medicine is being developed.

    Erfahren hier Sie mehr über ADA .

  • InfectoXplore

    Spektroskopische Plattform zur Diagnostik von Infektionen aus Blut

    Mit „InfectoXplore“ wird am InfectoGnostics Forschungscampus eine Diagnostik-Plattform aufgebaut, mit der erstmals auch aus Blutkulturen eine umfassende Raman-spektroskopische Erreger-Analyse durchgeführt werden kann.

    Erfahren hier Sie mehr über InfectoXplore .

  • Resistovac

    Testformate zur schnellen Erfassung des Impfstatus

    Im Projekt „RESISTOVAC“ werden verschiedene Testformate entwickelt, die zur schnellen Erfassung des Impfstatus von Menschen und Tieren eingesetzt werden können und so entscheidend zur Prävention von Infektionskrankheiten weltweit beitragen sollen.

    Erfahren hier Sie mehr über Resistovac .

  • Preplex

    Maschinelles Lernen zur Identifikation molekularer Muster

    Durch maschinelles Lernen sollen im Projekt „PREPLEX“ molekulare Muster identifiziert werden, die einen Hinweis darauf geben, wie Bakterien die Wirkmechanismen von Antibiotika außer Kraft setzen.

    Erfahren hier Sie mehr über Preplex .

  • POCT-ambulant

    Forschungs-Entwicklungs-Praxis-Dialog zur bedarfsgerechten Entwicklung von PoC-Tests

    Mit „POCT-ambulant“ entwickelt der Forschungscampus ein strukturiertes und systematisches Programm zur Beurteilung des Patientennutzens und des klinischen Bedarfes von Vor-Ort-Testverfahren (sogenannten Point-of-Care-Verfahren) im niedergelassenen Bereich.

    Erfahren hier Sie mehr über POCT-ambulant .

  • FastAlert

    Früherkennung von Erregern und Resistenzen in Abwasser

    In „FastAlert“ soll ein Analysesystem zur prozessnahen Erregerdetektion in Abwasseranlagen entstehen, um Infektionserreger und Resistenzgene zu überwachen.

    Erfahren hier Sie mehr über FastAlert .


Under the maxim "diagnostics before therapy", we successfully realise projects as a public-private partnerships (PPP) with strong partners from industry and science. On the page "partners" you will find an overview of all our campus members.  Here you can first get to know a random selection of our partners: